Home506820 • BOM
add
Astrazeneca Pharma India Ltd
Nakaraang pagsara
₹6,496.65
Sakop ng araw
₹6,442.25 - ₹6,545.00
Sakop ng taon
₹4,050.15 - ₹8,139.85
Market cap
160.82B INR
Average na Volume
1.60K
P/E ratio
196.91
Dividend yield
0.37%
Primary exchange
NSE
Mga balita tungkol sa merkado
MarketWatch
1 araw ang nakalipas
Wall Street sees ‘no alternative’ to U.S. stocks in 2025. Here’s why.
0.072%
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 4.08B | 31.16% |
Gastos sa pagpapatakbo | 1.39B | -0.72% |
Net na kita | 384.30M | -26.62% |
Net profit margin | 9.42 | -44.06% |
Kita sa bawat share | — | — |
EBITDA | 498.35M | -5.65% |
Aktuwal na % ng binabayarang buwis | 24.69% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 4.97B | -4.51% |
Kabuuang asset | 12.41B | 12.69% |
Kabuuang sagutin | 5.62B | 25.83% |
Kabuuang equity | 6.79B | — |
Natitirang share | 25.00M | — |
Presyo para makapag-book | 23.91 | — |
Return on assets | — | — |
Return on capital | 15.29% | — |
Cash Flow
Net change in cash
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 384.30M | -26.62% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Itinatag
1979
Website
Mga Empleyado
800
